Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.380
+0.022 (6.06%)
At close: Dec 20, 2024, 2:32 PM
0.360
-0.020 (-5.26%)
After-hours: Dec 20, 2024, 4:07 PM EST

Xtant Medical Holdings Revenue

Xtant Medical Holdings had revenue of $27.94M in the quarter ending September 30, 2024, with 11.66% growth. This brings the company's revenue in the last twelve months to $113.86M, up 45.11% year-over-year. In the year 2023, Xtant Medical Holdings had annual revenue of $91.30M with 57.50% growth.

Revenue (ttm)
$113.86M
Revenue Growth
+45.11%
P/S Ratio
0.42
Revenue / Employee
$529,591
Employees
215
Market Cap
50.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202391.30M33.33M57.50%
Dec 31, 202257.97M2.71M4.90%
Dec 31, 202155.26M1.93M3.61%
Dec 31, 202053.34M-11.35M-17.54%
Dec 31, 201964.68M-7.52M-10.42%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spero Therapeutics 106.46M
SHL Telemedicine 55.94M
Celularity 48.20M
Cytosorbents 37.74M
Dyadic International 3.36M
Singular Genomics Systems 2.67M
Exicure 500.00K
Revenue Rankings